Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alliance Boots Taps Retired Zuellig Pharma CEO to Lead Asia Operation, With M&A On The Mind

This article was originally published in PharmAsia News

Executive Summary

Major UK pharmaceutical and beauty products distributor Alliance Boots announced the appointment of retired Zuellig Pharma CEO Fritz Horlacher to head its heathcare division in Asia. The company aims to expand in Asia, especially in Thailand and Korea, which will pose a big challenge to Zuellig and other heavyweight pharmaceutical distributors
Advertisement

Related Content

Alliance Boots Doubles Down In China With 12% Stake Of Nanjing Pharma
Reading The Pharma Tea Leaves: China Market Heating Up
Walgreens Grows Internationally With Alliance Boots Stake
China’s New Guidelines On Foreign Investment Loosens Restrictions On Drug Distribution
China’s New Guidelines On Foreign Investment Loosens Restrictions On Drug Distribution
Invida Charts 25% Growth Plan, Banking On Selective Partnerships For High-value Products
Cardinal Eyeing Further Acquisitions In China
Cardinal Eyeing Further Acquisitions In China
Advertisement
UsernamePublicRestriction

Register

SC077689

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel